IOM recommends dumping 510(k) process

The Institute of Medicine (IOM) recommended that the Food and Drug Administration (FDA) dump the 510(k) process claiming the process is too flawed. The IOM stated the “FDA’s finite resources would be better invested in developing an integrated pre-market and post-market regulatory framework that provides a reasonable assurance of safety and effectiveness throughout the device life cycle.
Of course, the FDA does not agree. In addition, neither does the Advanced Medical Technology Association nor the Medical Imaging and Technology Alliance.


Contact ABISA, a consultancy specializing in solo and small group practice management. Visit us at

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s